• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    6/2/22 1:27:44 PM ET
    $ACOR
    $ADN
    $AERI
    $AFIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ACOR alert in real time by email

     

    During the Thursday's session, 100 stocks hit new 52-week lows.

    Areas of Significance In Today's 52-Week Lows:

    • Medtronic (NYSE:MDT) was the largest firm by market cap to set a new 52-week low.
    • Acorda Therapeutics (NASDAQ:ACOR) was the smallest company by market cap to set a new 52-week low.
    • Immunic (NASDAQ:IMUX)'s stock moved significantly downwards, trading down 43.14% to reach a new 52-week low.
    • Sutro Biopharma (NASDAQ:STRO) was the most promising stock of the group, with shares actually trading up 0.0% to bounce back after reaching its new 52-week low.

    On Thursday, the following stocks set new 52-week lows:

    • Medtronic (NYSE:MDT) shares were up 0.44% for the day, having made a 52-week low of $96.12.
    • Healthpeak Properties (NYSE:PEAK) shares hit a yearly low of $28.55. The stock was down 1.5% on the session.
    • James Hardie Industries (NYSE:JHX) stock drifted down 0.56% on Thursday morning to hit a new 52-week low of $24.44.
    • Ciena (NYSE:CIEN) shares set a new yearly low of $46.60 this morning. The stock was down 5.0% on the session.
    • Carvana (NYSE:CVNA) shares reached a new 52-week low of $25.31 on Thursday morning, moving up 6.08%.
    • Empire State Realty OP (NYSE:FISK) shares were down 5.16% for the day, having made a 52-week low of $7.41.
    • PTC Therapeutics (NASDAQ:PTCT) shares were down 3.71% for the day, having made a 52-week low of $27.05.
    • Canopy Gwth (NASDAQ:CGC) shares reached a new 52-week low of $4.56 on Thursday morning, moving up 1.17%.
    • Xencor (NASDAQ:XNCR) stock set a new 52-week low of $21.08 on Thursday, moving down 1.33%.
    • Celldex Therapeutics (NASDAQ:CLDX) shares set a new 52-week low of $21.68. The stock traded down 2.42%.
    • Iovance Biotherapeutics (NASDAQ:IOVA) stock hit a yearly low of $6.18. The stock was up 1.02% for the day.
    • Community Health Systems (NYSE:CYH) shares hit a yearly low of $4.96. The stock was up 0.45% on the session.
    • Big Lots (NYSE:BIG) shares were up 3.58% for the day, having made a 52-week low of $22.29.
    • Bright Green (NASDAQ:BGXX) stock hit a new 52-week low of $3.31. The stock was up 13.0% on the session.
    • Gladstone Land (NASDAQ:LANDM) stock drifted down 0.16% on Thursday morning to hit a new 52-week low of $25.15.
    • PMV Pharma (NASDAQ:PMVP) shares were up 4.26% for the day, having made a 52-week low of $11.19.
    • Coherus BioSciences (NASDAQ:CHRS) shares set a new yearly low of $7.01 this morning. The stock was down 2.38% on the session.
    • RCI Hospitality Holdings (NASDAQ:RICK) stock broke to a new 52-week low of $49.50 on Thursday. Shares of the company traded up 2.94%.
    • AnaptysBio (NASDAQ:ANAB) shares hit a yearly low of $18.20. The stock was down 2.22% on the session.
    • MVB Financial (NASDAQ:MVBF) stock hit a yearly low of $36.35. The stock was down 0.33% for the day.
    • Inhibrx (NASDAQ:INBX) shares set a new yearly low of $10.92 this morning. The stock was down 0.71% on the session.
    • Innovid (NYSE:CTV) stock set a new 52-week low of $2.99 on Thursday, moving down 12.43%.
    • D-MARKET Electronic (NASDAQ:HEPS) stock hit a yearly low of $1.17. The stock was down 3.63% for the day.
    • Ouster (NYSE:OUST) shares fell to $2.01 on Thursday, setting a new 52-week low with a shift of up 2.96%.
    • OrganiGram Holdings (NASDAQ:OGI) shares set a new yearly low of $1.08 this morning. The stock was up 2.7% on the session.
    • BARK (NYSE:BARK) shares set a new 52-week low of $1.90. The stock traded down 5.73%.
    • Cepton (NASDAQ:CPTN) shares made a new 52-week low of $2.26 on Thursday. The stock was down 2.55% for the day.
    • LexinFintech Holdings (NASDAQ:LX) stock hit a new 52-week low of $1.84. The stock was down 0.26% on the session.
    • Centessa Pharmaceuticals (NASDAQ:CNTA) stock hit a new 52-week low of $3.59. The stock was down 19.67% on the session.
    • SeaSpine Holdings (NASDAQ:SPNE) shares hit a yearly low of $7.61. The stock was down 0.38% on the session.
    • Oaktree Acquisition (NYSE:OACB) shares were down 8.13% for the day, having made a 52-week low of $8.96.
    • Conn's (NASDAQ:CONN) stock hit a new 52-week low of $11.15. The stock was down 10.14% on the session.
    • Aerie Pharmaceuticals (NASDAQ:AERI) stock achieved a new 52-week low on Thursday morning, hitting $4.81 and moving up 2.83%.
    • Fathom Digital Mfg (NYSE:FATH) stock achieved a new 52-week low on Thursday morning, hitting $4.66 and moving down 1.87%.
    • Dyne Therapeutics (NASDAQ:DYN) shares made a new 52-week low of $4.30 on Thursday. The stock was up 2.05% for the day.
    • Airspan Networks Hldgs (AMEX:MIMO) shares fell to $2.15 on Thursday, setting a new 52-week low with a shift of up 4.33%.
    • bluebird bio (NASDAQ:BLUE) stock hit $2.87 on Thursday morning, setting a new 52-week low for a change of up 1.18%.
    • Macrogenics (NASDAQ:MGNX) stock set a new 52-week low of $3.26 on Thursday, moving up 0.3%.
    • POET Technologies (NASDAQ:POET) shares hit a yearly low of $5.32. The stock was up 2.77% on the session.
    • Sutro Biopharma (NASDAQ:STRO) shares fell to $4.13 on Thursday, setting a new 52-week low with a shift of 0.0% (flat).
    • Jounce Therapeutics (NASDAQ:JNCE) shares reached a new 52-week low of $3.59 on Thursday morning, moving up 1.37%.
    • Viking Therapeutics (NASDAQ:VKTX) stock hit $2.10 on Thursday morning, setting a new 52-week low for a change of up 1.41%.
    • Personalis (NASDAQ:PSNL) stock hit a new 52-week low of $3.51. The stock was up 0.97% on the session.
    • XBiotech (NASDAQ:XBIT) stock achieved a new 52-week low on Thursday morning, hitting $5.18 and moving up 4.61%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) stock hit $4.05 on Thursday morning, setting a new 52-week low for a change of down 7.22%.
    • First Community (NASDAQ:FCCO) shares hit a yearly low of $18.01. The stock was down 0.76% on the session.
    • United Security (NASDAQ:UBFO) shares set a new 52-week low of $7.24. The stock traded down 1.49%.
    • NeuroPace (NASDAQ:NPCE) shares set a new 52-week low of $4.90. The stock traded down 1.62%.
    • Paratek Pharmaceuticals (NASDAQ:PRTK) shares set a new yearly low of $1.60 this morning. The stock was up 0.8% on the session.
    • So-Young Intl (NASDAQ:SY) stock hit a yearly low of $0.95. The stock was up 1.04% for the day.
    • Electric Last Mile Solns (NASDAQ:ELMS) stock hit a yearly low of $0.56. The stock was down 1.48% for the day.
    • Advent Technologies Hldgs (NASDAQ:ADN) stock drifted up 6.15% on Thursday morning to hit a new 52-week low of $1.26.
    • Centogene (NASDAQ:CNTG) shares reached a new 52-week low of $2.56 on Thursday morning, moving down 8.57%.
    • Kirkland's (NASDAQ:KIRK) stock broke to a new 52-week low of $4.75 on Thursday. Shares of the company traded down 3.99%.
    • Atreca (NASDAQ:BCEL) shares set a new yearly low of $1.51 this morning. The stock was down 3.77% on the session.
    • BioVie (NASDAQ:BIVI) shares were down 1.71% for the day, having made a 52-week low of $2.25.
    • Codiak BioSciences (NASDAQ:CDAK) shares were up 1.2% for the day, having made a 52-week low of $2.48.
    • Visionary Education Tech (NASDAQ:VEDU) shares set a new 52-week low of $1.33. The stock traded down 6.12%.
    • iBio (AMEX:IBIO) stock dropped to a yearly low on Thursday of $0.22. Shares traded down 0.57%.
    • Elevation Oncology (NASDAQ:ELEV) shares made a new 52-week low of $2.08 on Thursday. The stock was down 2.76% for the day.
    • Athenex (NASDAQ:ATNX) stock hit a new 52-week low of $0.42. The stock was down 2.45% on the session.
    • Aquestive Therapeutics (NASDAQ:AQST) stock hit a new 52-week low of $0.95. The stock was down 1.75% on the session.
    • Sera Prognostics (NASDAQ:SERA) shares were down 2.27% for the day, having made a 52-week low of $1.28.
    • Helbiz (NASDAQ:HLBZ) stock hit $0.91 on Thursday morning, setting a new 52-week low for a change of down 0.95%.
    • Spero Therapeutics (NASDAQ:SPRO) stock hit $1.03 on Thursday morning, setting a new 52-week low for a change of down 3.57%.
    • Renovacor (AMEX:RCOR) shares hit a yearly low of $1.68. The stock was down 7.18% on the session.
    • T2 Biosystems (NASDAQ:TTOO) shares hit a yearly low of $0.19. The stock was down 2.9% on the session.
    • TRACON Pharma (NASDAQ:TCON) shares reached a new 52-week low of $1.60 on Thursday morning, moving down 1.62%.
    • Regis (NYSE:RGS) stock broke to a new 52-week low of $0.67 on Thursday. Shares of the company traded down 0.58%.
    • Cumberland (NASDAQ:CPIX) shares reached a new 52-week low of $1.99 on Thursday morning, moving down 4.78%.
    • Lixiang Education Hldg (NASDAQ:LXEH) stock hit a new 52-week low of $1.90. The stock was down 8.09% on the session.
    • Assure Hldgs (NASDAQ:IONM) stock set a new 52-week low of $1.55 on Thursday, moving down 7.54%.
    • Medigus (NASDAQ:MDGS) stock hit a yearly low of $0.78. The stock was up 1.22% for the day.
    • Panbela Therapeutics (NASDAQ:PBLA) stock dropped to a yearly low on Thursday of $1.44. Shares traded down 0.19%.
    • Acutus Medical (NASDAQ:AFIB) shares set a new yearly low of $0.61 this morning. The stock was down 3.22% on the session.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) stock dropped to a yearly low on Thursday of $0.60. Shares traded down 5.36%.
    • WiSA Technologies (NASDAQ:WISA) stock broke to a new 52-week low of $0.63 on Thursday. Shares of the company traded down 13.87%.
    • Sharps Technology (NASDAQ:STSS) stock hit a yearly low of $1.03. The stock was down 1.83% for the day.
    • Histogen (NASDAQ:HSTO) stock achieved a new 52-week low on Thursday morning, hitting $0.13 and moving down 12.21%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ADN
    $AERI
    $AFIB

    CompanyDatePrice TargetRatingAnalyst
    Medtronic plc.
    $MDT
    2/9/2026$121.00Hold → Buy
    Needham
    First Community Corporation
    $FCCO
    2/3/2026$32.00 → $34.00Outperform
    Hovde Group
    Medtronic plc.
    $MDT
    2/3/2026$117.00Buy
    Citigroup
    Medtronic plc.
    $MDT
    1/30/2026$114.00Overweight
    Wells Fargo
    PTC Therapeutics Inc.
    $PTCT
    1/28/2026$119.00Overweight
    Barclays
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Coherus Oncology Inc.
    $CHRS
    1/23/2026$10.00Outperform
    Oppenheimer
    Ciena Corporation
    $CIEN
    1/20/2026Buy → Neutral
    BofA Securities
    More analyst ratings

    $ACOR
    $ADN
    $AERI
    $AFIB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medtronic upgraded by Needham with a new price target

    Needham upgraded Medtronic from Hold to Buy and set a new price target of $121.00

    2/9/26 6:45:10 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hovde Group reiterated coverage on First Community with a new price target

    Hovde Group reiterated coverage of First Community with a rating of Outperform and set a new price target of $34.00 from $32.00 previously

    2/3/26 9:52:01 AM ET
    $FCCO
    Major Banks
    Finance

    Citigroup resumed coverage on Medtronic with a new price target

    Citigroup resumed coverage of Medtronic with a rating of Buy and set a new price target of $117.00

    2/3/26 6:56:06 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Reynolds E. Leland bought $14,835 worth of shares (500 units at $29.67), increasing direct ownership by 2% to 30,930 units (SEC Form 4)

    4 - FIRST COMMUNITY CORP /SC/ (0000932781) (Issuer)

    2/2/26 3:49:56 PM ET
    $FCCO
    Major Banks
    Finance

    Director Cordella Richard James Jr bought $13,850 worth of Common Stock (500 units at $27.70) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    12/8/25 11:04:59 AM ET
    $MVBF
    Major Banks
    Finance

    Chief Financial Officer Sumbs Michael Robert bought $52,000 worth of Common Stock (2,000 units at $26.00) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    11/5/25 3:16:16 PM ET
    $MVBF
    Major Banks
    Finance

    $ACOR
    $ADN
    $AERI
    $AFIB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Xencor Inc.

    SCHEDULE 13G - Xencor Inc (0001326732) (Subject)

    2/9/26 8:12:57 AM ET
    $XNCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by PTC Therapeutics Inc.

    SCHEDULE 13G - PTC THERAPEUTICS, INC. (0001070081) (Subject)

    2/9/26 7:59:26 AM ET
    $PTCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ouster Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Ouster, Inc. (0001816581) (Filer)

    2/9/26 7:20:32 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $ACOR
    $ADN
    $AERI
    $AFIB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Keutzer Timothy was granted 68,000 shares and sold $101,175 worth of shares (46,586 units at $2.17), increasing direct ownership by 3% to 761,158 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/5/26 6:30:03 AM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Rajavelu Esther was granted 249,000 shares and sold $40,572 worth of shares (18,442 units at $2.20), increasing direct ownership by 27% to 1,100,008 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/4/26 9:44:22 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kamdar Kim P. disposed of 30,920 shares and acquired 3,231 shares, increasing direct ownership by 11% to 32,573 units (SEC Form 4)

    4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)

    2/4/26 5:03:47 PM ET
    $SERA
    Medical Specialities
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Leadership Updates

    Live Leadership Updates

    View All

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors

    BOSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors, effective January 1, 2026. Dr. Incerti is a highly accomplished executive with a strong background in medicine and over 35 years of strategic experience in the biopharmaceutical industry. "Carlo's appointment comes at a pivotal moment for Sparrow as we are looking ahead to pivotal trials of clofutriben for type 2 diabetes and seeking to expand development into other cardiometabolic indications," said Robert Jacks, Sparrow President and Chief Executive Officer. "Carlo is respected globally for

    2/2/26 8:30:00 AM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer

    Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the appointment of Neil Aubuchon as chief commercial officer. Mr. Aubuchon brings more than two decades of biopharmaceutical industry experience spanning leadership roles across global commercial and marketing functions including focus within the cardiometabolic space.

    1/7/26 7:00:00 AM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Celldex to Present at Upcoming Investor Conferences

    HAMPTON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences: Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11 at 3:30 pm ETTD Cowen 46th Annual Health Care Conference on Wednesday, March 4 at 9:10 am ETLeerink Global Healthcare Conference on Tuesday, March 10 at 3:40 pm ET Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event. About CelldexCelldex is pioneering new horizons in immunology to deliv

    2/9/26 8:01:00 AM ET
    $CLDX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Ouster Acquires StereoLabs, Creating a World-Leading Physical AI Sensing and Perception Company

    Ouster now offers a unified platform of high-performance digital lidar, cameras, AI compute, sensor fusion and perception software, and cutting-edge AI models StereoLabs brings AI vision solutions, expanded software capabilities, and over 10,000 customers Builds on Ouster's momentum, compounding the success of its lidar business and expanding its total addressable market StereoLabs is a high growth, EBITDA positive business that reinforces Ouster's path to profitability Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today that on February 4, 2026 it closed the acquisition of StereoLabs SAS ("StereoLabs"), a

    2/9/26 4:30:00 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

    SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced data demonstrating a best-in-class profile for commercial Amtagvi® (lifileucel) with unprecedented response rates in a real-world clinical, retrospective study in patients with advanced (unresectable or metastatic) melanoma. Amtagvi is the first one-time T cell therapy for a solid tumor cancer as well as the only FDA-approved treatment for advanced melanoma patients previously treated with anti-PD-1 and ta

    2/5/26 5:15:00 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Financials

    Live finance-specific insights

    View All

    Ouster Acquires StereoLabs, Creating a World-Leading Physical AI Sensing and Perception Company

    Ouster now offers a unified platform of high-performance digital lidar, cameras, AI compute, sensor fusion and perception software, and cutting-edge AI models StereoLabs brings AI vision solutions, expanded software capabilities, and over 10,000 customers Builds on Ouster's momentum, compounding the success of its lidar business and expanding its total addressable market StereoLabs is a high growth, EBITDA positive business that reinforces Ouster's path to profitability Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today that on February 4, 2026 it closed the acquisition of StereoLabs SAS ("StereoLabs"), a

    2/9/26 4:30:00 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Ciena Announces Reporting Date and Web Broadcast for Fiscal First Quarter 2026 Results

    Ciena® Corporation (NYSE:CIEN), the global leader in high-speed connectivity, expects to announce its fiscal first quarter financial results on Thursday, March 5, 2026 before the open of the financial markets. The press release will be available on Ciena's website at www.ciena.com. In conjunction with the announcement, Ciena will post an additional set of supporting materials to the Quarterly Results page of the Investor Relations section of its website. Ciena's management will then host a live audio web broadcast beginning at 8:30 a.m. Eastern accessible via www.ciena.com. Rebroadcast Information For those listeners unable to participate in the live web broadcast, an archived version

    2/5/26 9:00:00 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026

    WARREN, N.J., Feb. 5, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the company will host a webcast conference call to report its fourth quarter and full year 2025 financial results and provide an update on the company's business and outlook on Thursday, Feb. 19, 2026, at 4:30 p.m. ET. To access the call by phone, please click here to register and you will be provided with dial-in details. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call w

    2/5/26 8:00:00 AM ET
    $PTCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care